TA

Tour De Cure Australia

www.tourdecure.com.au link_icon

Tour de Cure Australia: Market and Competitor Analysis



Overview



Tour de Cure Australia is a renowned Australian charity that focuses on fundraising for cancer research, support, and prevention programs. Established in 2007, the organization has raised over $130 million, supporting 1019 cancer projects and contributing to 156 significant cancer breakthroughs. The charity engages in various events and collaborates with over 20 corporate partners to support researchers, surgeons, and clinicians dedicated to curing cancer.

Events and Initiatives



Tour de Cure is recognized for its flagship events:
  • Signature Tour 2025: A transformative cycling event from Airlie Beach to Port Douglas.

  • VIC Discovery Tour 2024: Supports cancer research institutions, including the Olivia Newton-John Cancer Research Institute.


The organization also hosts various other events, such as walks, virtual events, and gala dinners, to engage supporters and generate funds.

Leadership Team and Board Members



The strategic operations of Tour de Cure are guided by an esteemed board of directors:

  • Bruno Maurel, OAM: The founding Chairman with extensive experience in marketing and retail, contributing significantly to the charity's growth over the past 14 years.


  • Mark Beretta, OAM: Australia's distinguished sports presenter and board member since 2011, who uses his extensive network for fundraising and promotion.


  • Dominique Robinson, OAM: Expert in commercial and property law, on the board since 2008, and chairs the Gala Events Committee.


  • David Mann: CEO of Workplace Giving Australia, focuses on corporate philanthropy to elevate the charity’s impact and chairs the Audit & Risk Committee.


Other influential members include Dave Curran, former Westpac CIO focusing on resilience; Nikki Lawson, seasoned in retail operations; and Andrew Leakey, with over 30 years in FMCG and consumer healthcare.

Financial and Operational Highlights



Tour de Cure operates by integrating fundraising activities with strategic partnerships. Emphasis on cost-effective management ensures that a significant portion of funds directly benefits cancer research, prevention, and support initiatives. The charity has consistently achieved success in facilitating cancer research breakthroughs.

Contact Information



To engage with Tour de Cure Australia's projects:
  • Phone: (02) 8073 4000

  • Email: info@tourdecure.com.au

  • Address: PO Box 3208, Allambie Heights, NSW, 2100



Competitor Analysis



Key Competitors



1. Australian Cancer Research Foundation (ACRF)
  • Founded in 1984, ACRF is a leading entity funding extensive cancer research projects and has invested over $174 million in research infrastructure.


2. Ovarian Cancer Research Foundation (OCRF)
  • As Australia's premiere independent ovarian cancer research funder since 2000, OCRF focuses on early detection and treatment enhancements, engaging in broad partnerships for fundraising.


3. Pediatric Cancer Research Foundation (PCRF)
  • Based in Irvine, CA, since 1982, PCRF funds innovative projects for childhood cancer and supports 3.8% of highest-rated research applications.


4. Lung Foundation Australia
  • Founded in 1990, it’s the only Australian charity specializing in lung health, funding research, and providing support for lung-related diseases.


5. Cancer Council Australia
  • Established in 1961, this organization coordinates non-government cancer control efforts nationwide, focusing on research, prevention, and public policy advocacy.


Strategic Insights



  • Tour de Cure faces competition from well-established organizations with focused research domains and strong partnership networks.

  • Strategic opportunities for growth might involve emphasizing niche cancer research areas or using innovative marketing for event engagement.

  • Using empathy in narratives and ambassador-driven campaigns can emulate OCRF's effective public engagement strategy.

  • Collaborations for fund-matching or co-branded events with corporate partners can bolster fundraising and broaden Tour de Cure's mission reach.


By leveraging insights from competitors' strategies and frameworks, Tour de Cure can optimize its operations to increase fundraising efficiency, ultimately strengthening its contributions towards cancer research across Australia.